January 31st 2023
According to the company, the approval allows Eyenuk’s EyeArt AI eye screening system, already approved for detection of diabetic retinopathy, to aid millions of additional patients at risk for vision loss.
January 30th 2023
Minimally invasive, novel system achieves significant pressure level reductions.
January 29th 2023
Tailored approach can help physicians provide better outcomes for patients
January 26th 2023
Based on their findings, an international team of researchers is discouraging the application of atropine as a standard therapy for trabeculectomy surgery.
January 24th 2023
All events in the 2023 annual gathering, scheduled for February 2 to 4 in downtown San Francisco, California, will take place at a new venue, The Westin St Francis San Francisco on Union Square.
EnVision Summit 2023: Unique program takes family friendly conference to new heights
Bonnie An Henderson, MD, founder and program director of EnVision Summit, previews what attendees can expect at this year’s meeting - from its diverse faculty to an inclusive Youth Program, while also giving back to the community. The conference will take place February 17 to 20 at the El Conquistador Resort in Fajardo, Puerto Rico.
XEN continues to evolve for use in glaucoma surgery
Patient-tailored techniques result in predicable outcomes for patients.
Ocular implants can be a gateway to better glaucoma care
Until new innovations began transforming the field a decade ago, ophthalmologists had a limited toolbox. This option allows ophthalmologists to provide positive outcomes for their patients.
New high-tech startup developing smart contact lenses for glaucoma diagnosis and management
BVS Sight Inc. was created through a partnership between Boomerang Ventures and Purdue Research Foundation.
Bausch + Lomb and Glaucoma Research Foundation announce launch of campaign in recognition of Glaucoma Awareness Month
New educational campaign aims to educate individuals at risk for glaucoma and raise funding for glaucoma research.
ICYMI: Genetics of glaucoma
Janey Wiggs, MD, PhD, associate chief of Ophthalmology Clinical Research at Massachusetts Eye & Ear discusses genetics of glaucoma, providing an overview of what is known about genes and gene mutations that can cause or contribute to glaucoma.
Study reveals the signaling cascade behind retina regeneration in zebrafish
According to a team of investigators from the University of Michigan, the findings could help inform treatments for blindness in humans.
Thea receives FDA approval for preservative-free latanoprost for IOP reduction
The drug is expected to be available to eye care clinicians in the US during the second half of 2023.
New genetic mutation behind childhood glaucoma identified
Researchers found through DNA sequencing and confirmed in further testing that a genetic mutation in the THBS1 gene led to the development of severe childhood glaucoma. The discovery may improve disease screening and personalize treatments.
UCI-led study shows repeated stress accelerates aging of the eye
According to investigators, retinal aging caused by stress produces symptoms similar to those resulting from natural aging.
UC Davis tests microshunt in children with refractory childhood glaucoma
The case series included 12 eyes of children with refractory childhood glaucoma who needed trabeculectomy or implantation of a glaucoma drainage device.
ViaLase announces appointments to executive team
Company officials will drive global commercialization strategy for the company’s novel, non-invasive micron-accurate, OCT-guided femtosecond laser procedure for the treatment of glaucoma.
Company launches the NT-1p non-contact tono/pachymeter
By placing the chin on the chinrest, Nidek’s NT-1p automatically detects the position of the eyes and begins measurement without pressing any buttons.
Study: US ophthalmology residency programs rank last for diversity
According to UC Davis researchers, more needs to be done for the field to reflect ethnic and racial diversity across the country.
EP. 5: EyeCon 2022: Last chance to earn those end-of-year CME credits
This December, the Ophthalmology Times® EyeCon 2022 at the JW Marriott Marco Island Beach Resort in Florida will provide attendees with an end-of-year opportunity to meet their continuing medical education requirements. This activity has been approved for 12.50 AMA PRA Category 1 Credits™.
Nicox outlines future development, partnership plans for NX 470 in glaucoma
The company said it plans to generate clinical data aiming to demonstrate the potential retinal benefits of NCX 470 in order to add significant therapeutic value to the product profile in glaucoma.
Poor sleep quality may be linked to increased risk of irreversible sight loss
According to investigators, findings may underscore the need for sleep therapy in patients at risk for glaucoma, and frequent eye checkups for patients who are poor sleepers.
Private practice vs academics: What do young ophthalmologists need to know?
Nicole Bajic, MD, and Neel S. Vaidya, MD, MPH, share their insights from when they were at this crossroads. Learn more clinical pearls on topics like this and more at Real World Ophthalmology’s virtual conference, “Top 10 Things I Wish I Knew Sooner,” this Saturday, November 5.
Verana Health + AAO IRIS Registry joint initiative yields 3.5 million ophthalmic images
Lawrence Whittle, Chief Commercial Officer for Verana Health, explains what the significance of imaging data linked with electronic health record data means for patient outcomes.
Mont Blanc Phase 3 glaucoma trial for NCX 470 achieves primary objective
Nicox reports that daily dosing of NCX 470 0.1% met the primary efficacy objective of demonstrating non-inferiority to latanoprost 0.005%.
App brings virtual eye care to Bangladesh
The EyeBuddy app will bring telehealth to eye doctors in the coming months, connecting patients across Bangladesh with ophthalmologists at a major eye-care hospital.
Verana Research Network set sights on better access to clinical care
Marc Berger, Chief Operating Officer at Verana Health, highlights what a new initiative with the American Academy of Ophthalmology IRIS Registry will mean for patients and physicians.
Real World Ophthalmology 2022: Virtual meeting set for Nov 5
Complimentary registration is open for this unique meeting designed to prepare young ophthalmologists for success in early practice.
Not enough hours in the day
There literally are not enough hours in a day to allow physicians to comply with all the recommendations emanating from the various constituencies involved in issuing guidelines.
EP. 4: EyeCon 2022: Mindset to explore new opportunities for your practice
An interactive agenda at the Ophthalmology Times® EyeCon 2022 at the JW Marriott Marco Island Beach Resort in Florida will foster an open exchange of ideas with fellow attendees from across the United States.
Real World Ophthalmology networking offers early-practice career advice
Lisa M. Nijm, MD, JD, shares highlights from the Real World Ophthalmology 'After Dark' networking reception held at the American Academy of Ophthalmology annual meeting. The next Real World Ophthalmology meeting on November 5—which will be virtual—will cover important clinical, business, and personal growth areas for young ophthalmologists.
TearClear announces positive topline results from CLEAR phase 3 study of TC-002
According to the company, latanoprost ophthalmic solution 0.005% successfully met the primary and all secondary endpoints, and it plans to file an NDA with the FDA in Q1 2023.
Celebrating World Sight Day 2022
Hear how ophthalmologists and optometrists in the United States are recognizing the importance of this year's awareness day.
3D map reveals DNA organization within human retina cells
A team of National Institutes of Health scientists have shed light on how genetic architecture determines gene expression, tissue-specific function, and disease phenotype in blinding diseases.
Catalyst For A Cure initiative promoting prevention, cure for neurodegeneration
According to the Glaucoma Research Foundation, the collaborative research program will explore some of the common characteristics of glaucoma, Alzheimer’s.
2 Clarke Drive Cranbury, NJ 08512